Pfizer Inc. (PFE)
NYSE • Healthcare
October 2, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Pfizer Inc. currently loses $2.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 3
in 31 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Pfizer beat consensus on both revenue and adjusted EPS in the second fiscal quarter of 2026, reported Aug. 4 based on preliminary results, as revenue rose 2.6% to about $15.0 billion and adjusted EPS of $0.77 topped the $0.68 estimate by 12.9%. Revenue also came in above the $14.4 billion consensus and was up from $14.65 billion a year ago, while gross profit reached about $10.9 billion and operating income about $4.7 billion, leaving gross margin near 73% and operating margin around 31%. Operating cash flow was about $835 million, and Pfizer paid about $2.5 billion in dividends. Consensus for the next period calls for EPS of $0.82 on revenue of $16.10 billion.
About Pfizer Inc.
Pfizer Inc. develops, makes, and sells prescription medicines and vaccines worldwide. Listed on the NYSE as PFE, the company operates in the pharmaceutical business and generated $62.6 billion of revenue in FY2025. Its portfolio spans branded therapies, biosimilars, hospital injectables, and vaccines used across a wide range of treatment and prevention settings.
Today's Snapshot
PFE closed 1.2% lower at 27.79, while its sector was flat. PFE closed within 4.9% of its 52-week high of 29.21. Florida's attorney general sued Pfizer over alleged misleading COVID-19 vaccine claims.
Trading Volume
Below 10d avg (30.2M)
27.4M
vs S&P 500 Today
Underperforming Market
-1.95%
Updated: October 2, 2026 at 20:12 UTC
PFE Headlines
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$26.49 - $28.21Buy
- RSI (14)47.71Neutral
- Stochastic %K (14, 3, 3)52.75Neutral
- MACD Level (12, 26)0.24Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.